BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31425463)

  • 21. Cross-tapering clozapine and risperidone.
    Koreen AR; Lieberman JA; Kronig M; Cooper TB
    Am J Psychiatry; 1995 Nov; 152(11):1690. PubMed ID: 7485641
    [No Abstract]   [Full Text] [Related]  

  • 22. [The risperidone-associated neuroleptic malignant syndrome in a pediatric patient].
    Villanueva Lamas J; García García J; Alda Diez JA; Tous Andreu N
    An Esp Pediatr; 1998 Dec; 49(6):652-3. PubMed ID: 9972639
    [No Abstract]   [Full Text] [Related]  

  • 23. Risperidone-induced tardive dyskinesia.
    Bassitt DP; de Souza Lobo Garcia L
    Pharmacopsychiatry; 2000 Jul; 33(4):155-6. PubMed ID: 10958268
    [No Abstract]   [Full Text] [Related]  

  • 24. Risperidone-associated agranulocytosis.
    Finkel B; Lerner AG; Oyffe I; Sigal M
    Am J Psychiatry; 1998 Jun; 155(6):855-6. PubMed ID: 9619165
    [No Abstract]   [Full Text] [Related]  

  • 25. Risperidone induced stuttering.
    Yadav DS
    Gen Hosp Psychiatry; 2010; 32(5):559.e9-10. PubMed ID: 20851282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risperidone-induced retrograde ejaculation: case report and review of the literature.
    Loh C; Leckband SG; Meyer JM; Turner E
    Int Clin Psychopharmacol; 2004 Mar; 19(2):111-2. PubMed ID: 15076020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risperidone-induced hepatotoxicity.
    Benazzi F
    Pharmacopsychiatry; 1998 Nov; 31(6):241. PubMed ID: 9930641
    [No Abstract]   [Full Text] [Related]  

  • 28. Risperidone-induced rabbit syndrome: an unusual movement disorder caused by an atypical antipsychotic.
    Levin T; Heresco-Levy U
    Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):137-9. PubMed ID: 10082239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Weight gain associated with risperidone.
    Penn JV; Martini J; Radka D
    J Clin Psychopharmacol; 1996 Jun; 16(3):259-60. PubMed ID: 8784664
    [No Abstract]   [Full Text] [Related]  

  • 30. Successful therapy of massive risperidone-induced rhabdomyolysis using different dialysis and adsorber devices: A case report.
    Jarczak D; Kluge S; Fuhrmann V
    Artif Organs; 2019 Nov; 43(11):1113-1115. PubMed ID: 31140191
    [No Abstract]   [Full Text] [Related]  

  • 31. Dose-dependent acute excessive weight gain and metabolic changes in a drug-naive patient on risperidone are reversible with discontinuation: a case report.
    Sahoo S; Mishra B; Akhtar S
    Br J Clin Pharmacol; 2007 Nov; 64(5):715-6. PubMed ID: 17509037
    [No Abstract]   [Full Text] [Related]  

  • 32. Rapid onset psychosis after reduction of the risperidone dose.
    Molina JD; Solé S; Pablo Sd; López-Muñoz F; Santana G; Alamo C
    Pharmacopsychiatry; 2008 Jul; 41(4):160-3. PubMed ID: 18651347
    [No Abstract]   [Full Text] [Related]  

  • 33. Prolactogenic effects of risperidone in male patients--a preliminary study.
    Shiwach RS; Carmody TJ
    Acta Psychiatr Scand; 1998 Jul; 98(1):81-3. PubMed ID: 9696519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risperidone and hyponatremia: a case report.
    Whitten JR; Ruehter VL
    Ann Clin Psychiatry; 1997 Sep; 9(3):181-3. PubMed ID: 9339885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved long-term outcome with long-acting risperidone treatment of chronic schizophrenia with prior partial response.
    Lindenmayer JP; Parak M; Gorman JM
    J Psychiatr Pract; 2006 Jan; 12(1):55-7. PubMed ID: 16432447
    [No Abstract]   [Full Text] [Related]  

  • 36. Risperidone-induced anxiety might also develop 'awakening' phenomenon.
    Hori M; Shiraishi H
    Psychiatry Clin Neurosci; 1999 Dec; 53(6):682. PubMed ID: 10687752
    [No Abstract]   [Full Text] [Related]  

  • 37. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.
    Segal M; Avital A; Derevenski A; Berstein S; Sandbank S; Weizman A
    Int Clin Psychopharmacol; 2007 Jul; 22(4):192-6. PubMed ID: 17519641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Olanzapine-induced and Risperidone-induced Leukopenia: A Case of Synergistic Adverse Reaction?
    Woon LS; Tee CK; Gan LLY; Deang KT; Chan LF
    J Psychiatr Pract; 2018 Mar; 24(2):121-124. PubMed ID: 29509183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic syndrome in drug-naïve first-episode psychosis treated with atypical antipsychotics.
    Sahoo S; Ameen S; Akhtar S
    Aust N Z J Psychiatry; 2007 Jul; 41(7):629. PubMed ID: 17691161
    [No Abstract]   [Full Text] [Related]  

  • 40. A pilot double-blind, dose-comparison study of risperidone in drug-naive, first-episode schizophrenia.
    Lane HY; Chang WH; Chiu CC; Huang MC; Lee SH; Chen JY
    J Clin Psychiatry; 2001 Dec; 62(12):994-5. PubMed ID: 11780884
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.